Zepbound

Zepbound

Product

by Eli Lilly and Company

Heard in 44 episodes across 27 shows since Oct 2025

Zepbound is a brand name for tirzepatide, an injectable prescription medication developed by Eli Lilly and Company. It is approved for chronic weight management in adults with obesity or who are overweight with weight-related medical conditions.

Discussed inMarkets63%Politics16%Business11%Health & Science11%

Episodes

44
across 27 shows

This week

0
episodes on 0 shows

Share of the conversation

Mentions of Zepbound per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.03‰0.05‰0.07‰0.1‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Aug 290.01‰1
Sep 130.02‰2
Sep 170.04‰2
Sep 230.03‰1
Sep 300.02‰2
Oct 30.04‰2
Oct 50.04‰1
Oct 60.05‰1
Oct 200.02‰2
Oct 220.02‰1
Oct 280.02‰1
Oct 290.04‰4
Oct 300.05‰1
Oct 310.06‰1
Nov 10.08‰2
Nov 20.08‰1
Nov 50.05‰1
Nov 80.02‰1
Nov 90.04‰3
Nov 100.05‰1
Nov 170.02‰2
Nov 180.02‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Zepbound comes up on a podcast

One email a week at most, with the new episodes that mention Zepbound. Free, no account needed, unsubscribe in one click.

Episodes

44 episodes featuring Zepbound, newest first